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iTATE-OF-THE-ART PAPER1041Genetic Modifiers of the Response to Antithromboticsrancisco Marı´n, Rocı´o Gonza´lez-Conejero, Piera Capranzano, Theodore A. Bass, Vanessa Rolda´n,
ominick J. Angiolillo
olymorphisms affecting disposition, metabolism, transporters, or targets of a drug
an all modify an individual’s drug response and, therefore, the drug’s safety and
fficacy. This paper by Marı´n and colleagues reviews each of the major classes of
ntithrombotic medications and the various genetic variations that may modify the
linical benefit. Some examples include the reduced conversion of clopidogrel to its
ctive metabolite seen in patients with CYP2C19 (681GA) and the increased risk of
leeding and need for lower dosing in patients with CYP2C9 treated with warfarin.CLINICAL RESEARCH LINICAL TRIAL1058Atrial Natriuretic Peptide Infusion Prevents Renal Deterioration After Bypass Surgerykira Sezai, Mitsumasa Hata, Tetsuya Niino, Isamu Yoshitake, Satoshi Unosawa, Shinji Wakui,
hunji Osaka, Tadateru Takayama, Yuji Kasamaki, Atsushi Hirayama, Kazutomo Minami
ezai and colleagues previously reported that continuous infusion of low-dose human atrial
atriuretic peptide (hANP) during cardiopulmonary bypass (CPB) suppressed renin-
ngiotensin-aldosterone system activity and had a potent diuretic effect. For this study, 500
ubjects undergoing CPB were randomized to continuous infusions of hANP or placebo.
ost-operatively, the maximum post-operative creatinine level, the percent increase in
reatinine, and the need for hemodialysis were less frequent in the hANP group. Continuous
nfusion of low-dose hANP from the start of CPB prevents post-operative acute renal failure.(continued on page A-21)
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ENTERVENTIONAL CARDIOLOGY1065Intracoronary Streptokinase Improves Results of Primary PCIurat Sezer, Arif Çimen, Emre Aslanger, Ali Elitok, Berrin Umman, Zehra Bug˘ra, Ebru Yormaz,
üneyt Türkmen, Is¸k Adalet, Yilmaz Nis¸anci, Sabahattin Umman
ezer and colleagues hypothesized that intracoronary streptokinase (ICSK) given immediately
fter primary percutaneous coronary intervention (PCI) would break down microvascular
bstruction and improve tissue perfusion and thus left ventricular recovery. A total of 95
atients undergoing primary PCI were randomized to ICSK or no additional therapy, in
ddition to standard PCI medications including aspirin, clopidogrel, heparin, and tirofiban.
t 2 days, the fractional flow reserve and other indexes of microvascular function were
ignificantly better in the ICSK group. At 6 months, infarct size, left ventricular end-systolic
olume, and ejection fraction were all significantly better in the ICSK group. These results
uggest that ICSK improves tissue perfusion and limits infarct damage when given
mmediately after primary PCI.ARDIAC IMAGING1072Adenosine-Induced Stress MPI Using CTon Blankstein, Leon D. Shturman, Ian S. Rogers, Jose A. Rocha-Filho, David R. Okada, Ammar Sarwar,
nand V. Soni, Hiram Bezerra, Brian B. Ghoshhajra, Milena Petranovic, Ricardo Loureiro,
udrun Feuchtner, Henry Gewirtz, Udo Hoffmann, Wilfred S. Mamuya, Thomas J. Brady, Ricardo C. Cury
lankstein and colleagues developed and tested a protocol to assess myocardial perfusion
uring adenosine infusion using dual-source computed tomography (CT). Subjects who had
lready undergone single-photon emission computed tomography (SPECT) myocardial
erfusion imaging (MPI) underwent a CT protocol during which they received adenosine
hile the contrast was administered and the CT was performed. The results of the CT
erfusion study were then compared to the MPI images, to CT angiography data, and to
nvasive coronary angiography. Almost all SPECT MPI perfusion abnormalities with a
50% corresponding stenosis were detected by CT perfusion. CT angiography further
mproved the accuracy. Adenosine stress CT has diagnostic accuracy comparable to SPECT,
ith a similar radiation dose and with the advantage of visualizing coronary anatomy.
ditorial Comment: Stephan Achenbach, p. 1085(continued on page A-22)
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hEART RHYTHM DISORDERS1089Comparative Efficacy of Dronedarone and Amiodarone CMEonathan P. Piccini, Vic Hasselblad, Eric D. Peterson, Jeffrey B. Washam, Robert M. Califf, David F. Kong
ronedarone is a noniodinated amiodarone congener developed to have similar
lectrophysiologic properties with less toxicity than amiodarone. Piccini and colleagues
onducted a systematic overview of all randomized, controlled trials evaluating dronedarone or
miodarone for the prevention of atrial fibrillation (AF) to determine relative efficacy and
afety profiles, as there are limited direct comparison trials. A model incorporating all trial
vidence found amiodarone to be superior to dronedarone (odds ratio [OR]: 0.49) for the
revention of recurrent AF; however, there was a trend toward higher all-cause mortality
OR: 1.61) and higher overall adverse events requiring drug discontinuation with amiodarone
OR: 1.81). For every 1,000 patients treated with dronedarone instead of amiodarone, the
uthors estimate 228 more recurrences of AF in exchange for 9.6 fewer deaths and 62 fewer
dverse events requiring discontinuation of the drug.ditorial Comment: Paul S. Chan, Brahmajee K. Nallamothu, Hakan Oral, p. 1096ALVULAR HEART DISEASE1099BNP Useful for Predicting Outcomes in Patients With Severe MRodolfo Pizarro, Oscar O. Bazzino, Pablo F. Oberti, Mariano Falconi, Federico Achilli, Anibal Arias,
uan G. Krauss, Arturo M. Cagide
he purpose of this investigation by Pizarro and colleagues was to determine the prognostic
alue of brain natriuretic peptide (BNP) measurements in asymptomatic patients with severe
rganic mitral regurgitation (MR) and normal left ventricular (LV) function. BNP was
easured at baseline, and subjects were then followed for the development of LV
ysfunction, congestive heart failure, or death. Event-free survival was 93% for those with
NP 105 pg/ml and only 29% in those with higher BNP levels. Among patients with
evere, asymptomatic, organic MR, BNP 105 pg/ml identifies a subgroup of patients at
igher risk.ditorial Comment: Peter A. McCullough, George S. Hanzel, p. 1107FROM AROUND THE WORLD OCUS ON CHINA1110Regional Differences in the Incidence of SCD in Chinaei Hua, Lin-Feng Zhang, Yang-Feng Wu, Xiao-Qing Liu, Dong-Shuang Guo, Hong-Ling Zhou,
hi-Ping Gou, Lian-Cheng Zhao, Hong-Xia Niu, Ke-Ping Chen, Jin-Zhuang Mai, Li-Nan Chu,
hu Zhang
his study by Hua and colleagues explored the epidemiologic features of sudden cardiac
eath (SCD) in various regions of China by conducting a population-based surveillance study
n 4 socioeconomically diverse regions. Almost 700,000 residents were monitored and there
ere 2,983 all-cause deaths, including 284 SCDs. The overall incidence of SCD was 41.8 per
00,000 population per year (44.6 for men and 39.0 for women). The age-standardized
ncidence of SCD was highest in Yuxian, an undeveloped inland rural area with little access
o medical care. Further results suggest that targeting common cardiac conditions such as
ypertension and angina in Yuxian could reduce the incidence of SCD in this province.
